Cite
HARVARD Citation
Dasanu, C. et al. (2019). Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?. Journal of oncology pharmacy practice. pp. 214-216. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dasanu, C. et al. (2019). Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?. Journal of oncology pharmacy practice. pp. 214-216. [Online].